KK
TNGX icon

KLP Kapitalforvaltning’s Tango Therapeutics TNGX Stock Holding History

KLP Kapitalforvaltning’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$203K Hold
9,700
– – ﹤0.01% 1809
2025
Q4 		$85.9K Buy
+9,700
New +$83.6K ﹤0.01% 2107
2025
Q1 		– Sell
-6,300
Closed -$19.5K – 2293
2024
Q4 		$19.5K Buy
+6,300
New +$29.3K ﹤0.01% 2281

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

KLP Kapitalforvaltning's TNGX Position: Q1 2026 in Review

KLP Kapitalforvaltning held its Tango Therapeutics (TNGX) position steady in Q1 2026 at 9,700 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #1809.

KLP Kapitalforvaltning first reported a position in TNGX in Q4 2024 and has held it in 3 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • KLP Kapitalforvaltning held 9,700 shares of Tango Therapeutics worth $203K as of Q1 2026.
  • KLP Kapitalforvaltning left its Tango Therapeutics share count unchanged in Q1 2026.
  • Tango Therapeutics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #1809 holding.
  • KLP Kapitalforvaltning first reported a position in Tango Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.